MAP1LC3B and colorectal carcinoma: Survival analysis of CRC patients from cohort I with follow-up data indicated that high expression of Beclin-1, LC3B, and ATG7 was associated with shorter disease-free survival (P < 0.0001; Supplemental Fig. 1C).